JAK2 and cyclic hematopoiesis: Interestingly, the various somatic variants associated with CH result in heterogenous phenotypes with their own clinical consequences—for example, clones with DNTMT3A variants are most strongly associated with malignancy, whereas those involving JAK2 are associated with the highest degree of cardiovascular disease (Kessler et al., 2022).